Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor.
about
Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient dataErythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient dataErythropoietin Pathway: A Potential Target for the Treatment of DepressionCarbamylated Erythropoietin: A Prospective Drug Candidate for NeuroprotectionHypoxia: The Force that Drives Chronic Kidney DiseaseThe pleiotropic effects of erythropoietin in infection and inflammationErythropoietin-mediated protection in kidney transplantation: nonerythropoietic EPO derivatives improve function without increasing risk of cardiovascular eventsErythropoietin and Neonatal NeuroprotectionMolecular mechanisms of ischemic preconditioning in the kidneyBridging Translation by Improving Preclinical Study Design in AKIThe erythropoietin receptor is a downstream effector of Klotho-induced cytoprotectionA new agonist of the erythropoietin receptor, Epobis, induces neurite outgrowth and promotes neuronal survivalARA 290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain coupled with suppression of the spinal microglia responseDifferential modulation of angiogenesis by erythropoiesis-stimulating agents in a mouse model of ischaemic retinopathyNonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin.Use of high-dose erythropoietin for repair after injury: A comparison of outcomes in heart and kidney.A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury.Chronic administration of small nonerythropoietic peptide sequence of erythropoietin effectively ameliorates the progression of postmyocardial infarction-dilated cardiomyopathy.Ketamine does not produce relief of neuropathic pain in mice lacking the β-common receptor (CD131).Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAE.No evidence for protective erythropoietin alpha signalling in rat hepatocytes.Erythropoietin over-expression protects against diet-induced obesity in mice through increased fat oxidation in musclesErythropoietin overrides the triggering effect of DNA platination products in a mouse model of cisplatin-induced neuropathy.Cytokine Receptor Endocytosis: New Kinase Activity-Dependent and -Independent Roles of PI3K.Serum erythropoietin levels in patients with central serous chorioretinopathy.Improved cerebrovascular function and reduced histological damage with darbepoietin alfa administration after cortical impact injury in ratsA nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injuryEPO promotes bone repair through enhanced cartilaginous callus formation and angiogenesisErythropoietin action in stress response, tissue maintenance and metabolism.The Roles of Mechanical Stresses in the Pathogenesis of Osteoarthritis: Implications for Treatment of Joint Injuries.Evaluating erythropoietin-associated tumor progression using archival tissues from a phase III clinical trial.Erythropoietin ameliorates rat experimental autoimmune neuritis by inducing transforming growth factor-β in macrophages.Cardioprotection by a nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietinMethylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury.Transcriptional ontogeny of the developing liver.Erythropoietin molecules to treat acute ischemic stroke: a translational dilemma!Erythropoietin ameliorates early ischemia-reperfusion injury following the Pringle maneuver.Darbepoetin-mediated cardioprotection after myocardial infarction involves multiple mechanisms independent of erythropoietin receptor-common beta-chain heteroreceptor.The effect of erythropoietin on normal and neoplastic cells.
P2860
Q24240202-656ABC5F-916C-4154-A6A7-B0E5AF241611Q24242864-74FD273C-C8A0-4F53-91B5-4B52C11337BDQ26750850-2B039214-D821-403A-BBB8-71C556F02B1CQ26767146-3ADEC98B-315F-4BD5-A838-6E489192A975Q26768865-B84D5C8B-68BD-4C24-B7A1-8DCEFEDE118EQ26864149-43E0B928-C370-481F-987E-F3DF112A939EQ26866295-CB863830-83A8-4DED-AD39-DDDAC8323C18Q27009422-E0F68B6A-DA82-4661-ACCD-1C6E73F1E8C0Q28080772-ECF0936C-F993-4E76-ACBA-1F7F2DACD834Q28084530-91F21693-B3EF-4D91-871D-BC7DD67E8EBAQ28565261-7AF394DD-BC10-4668-9B63-A5660816A7F7Q28575057-336ACAD4-5EE0-45FE-B909-49F6DDCDE464Q28658933-3396AB76-9690-4BDB-BEC7-C96BD3036B3BQ28750073-ECEBD8DC-2F81-4F39-AF9B-E07A3E7CB7FDQ30483012-93A0D198-E562-4DD6-94A1-A6F3F93AF98EQ30486662-10F2DDDD-FDDF-402E-890D-09E76AB40CEAQ30502819-B779DD80-B9E4-4FBF-A9B5-03093BBDC929Q30539892-7306BC27-BCF0-4E93-89F5-CC0A1CC4DDD3Q31126222-4EC3E4B9-AA79-4223-8A7B-65D1FB34069FQ33288270-EF06D39D-35AE-4F4B-B2CD-B5A9C590BFF6Q33326648-F1272F7D-8445-4155-B49B-289D5C173B05Q33433206-F58B3F15-FDAB-4F13-B95D-2E9E031ECA07Q33466769-0A2BA997-6D72-4077-BC3B-92AC88768EFAQ33482074-63D767CC-A33E-4678-AAF2-A872D3AD0D19Q33619529-120032F8-4B8C-4340-896A-9206CABE141DQ33702107-23869E19-0CB7-4D27-A080-3109A9993935Q33804787-7C6E7FB3-90DB-42E0-8431-71F14A797419Q33836284-D9FE2AF0-297C-4707-810A-999AEB137C46Q33864364-E271604F-3A9B-40A2-8D27-F45DE3989662Q33907747-40FE41F7-E5B2-4698-8173-4463DE82D252Q33945565-AB2576E7-94C6-4086-A24A-5D22FFA426A7Q34024987-02ED72AB-87DB-4F93-9372-FC8C80135BB3Q34063671-1DDB20C3-5FF5-46B6-BA24-8E8A06F72843Q34069738-692662C6-BD3D-4045-AE4E-F5DEF6DC1D49Q34132516-55BE3CBC-23E9-4BA0-B01A-FC36CA393A7DQ34133406-7CE17BB2-E49D-4C31-A198-52CCEA77BFB7Q34164787-CA4FCDE4-0488-41A5-ADE2-AE432827817AQ34200868-FBF8E1C1-2A14-4760-97F7-A4286902A011Q34219629-52ECB19E-A9D7-40FD-B882-F82CBE8B1717Q34291437-38BB3BE7-506E-4A42-92E1-656937F5F3E6
P2860
Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 September 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Erythropoietin mediates tissue ...... n beta-subunit heteroreceptor.
@en
Erythropoietin mediates tissue ...... n beta-subunit heteroreceptor.
@nl
type
label
Erythropoietin mediates tissue ...... n beta-subunit heteroreceptor.
@en
Erythropoietin mediates tissue ...... n beta-subunit heteroreceptor.
@nl
prefLabel
Erythropoietin mediates tissue ...... n beta-subunit heteroreceptor.
@en
Erythropoietin mediates tissue ...... n beta-subunit heteroreceptor.
@nl
P2093
P2860
P356
P1476
Erythropoietin mediates tissue ...... n beta-subunit heteroreceptor.
@en
P2093
Alessandra Sfacteria
Anthony Cerami
Carla Hand
Chiao-Ju Su-Rick
Daniel Gomez
Deborah Diaz
Eileen Pobre
Fabio Fiordaliso
Giovanni Grasso
John Smart
P2860
P304
14907-14912
P356
10.1073/PNAS.0406491101
P407
P577
2004-09-29T00:00:00Z